The online version of this article (https://doi.org/10.1007/s10549-018-4956-y) contains supplementary material, which is available to authorized users.
Jin-Xiao Ren and Yue Gong contributed equally and share co-first authorship.
Population-based estimates of racial disparities in metastatic breast cancer are lacking. We quantified the contributions of demographic, socioeconomic, tumor, and metastatic characteristics to racial differences in metastatic breast cancer and characterized the most disproportional subgroup.
Patients diagnosed with metastatic breast cancer between 2010 and 2014 were identified using the Surveillance, Epidemiology, and End Results database. A multivariable Cox proportional hazards model was used to adjust each set of variables. The excess relative risk of cancer-specific and all-cause death in non-Hispanic black (NHB) versus non-Hispanic white women diagnosed with metastatic breast cancer was expressed as a percentage and was stratified by the age at diagnosis.
We identified 13,066 female patients. NHB women exhibited substantially higher morbidity and mortality than women of other races/ethnicities. The greatest excess mortality risk for NHB women was observed in the young-onset group (18–49 years; hazard ratio: 1.57), followed by the middle-age group (50–64 years; hazard ratio: 1.42); the trend was not significant among the elderly group. Socioeconomic factors stably explained one-half of the excess risk, whereas the contribution of tumor characteristics obviously decreased with age (18–49 years, 40.7%; 50–64 years, 33.9%), and the metastatic pattern accounted for approximately one-tenth of the excess risk. Additionally, the disproportional death burden of NHB women persisted in less aggressive subgroups.
By providing a comprehensive assessment of racial differences in the incidence and outcomes of patients with metastatic breast cancer, we urge the implementation of targeted preventive efforts in both the public health and clinical arenas.
Supplementary material 1 (PDF 259 KB)10549_2018_4956_MOESM1_ESM.pdf
Sighoko D, Hunt BR, Irizarry B et al (2018) Disparity in breast cancer mortality by age and geography in 10 racially diverse US cities. Cancer Epidemiol 53:178–183. https://doi.org/10.1016/j.canep.2018.02.003 CrossRefPubMed
Surveillance Research Program, National Cancer Institute SEER*Stat software ( http://www.seer.cancer.gov/seerstat) version 8.3.5
Surveillance, Epidemiology, and End Results (SEER) Program (2017) ( http://www.seer.cancer.gov) SEER*stat database: incidence—SEER 18 Regs excluding AK (with additional treatment fields), Nov 2017 Sub (2000–2015) < Vintage 2015 pops by race/origin tract 2000/2010 mixed geographies>—linked to census tract attributes—time dependent (2000–2015)—SEER 18 (excl AK) Census 2000/2010 Geographies with Index Field Quantiles, National Cancer Institute, DCCPS, Surveillance Research Program, released June 2018, based on the November 2017 submission.
Kish JK, Yu M, Percy-Laurry A (2014) Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries. J Natl Cancer Inst 2014:236–243. https://doi.org/10.1093/jncimonographs/lgu020 CrossRef
Yost K, Perkins C, Cohen R et al (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12:703–711 CrossRef
Surveillance, Epidemiology, and End Results (SEER) Program (2018) ( http://www.seer.cancer.gov) SEER*stat database: incidence-based mortality—SEER 18 Regs (Excl Louisiana) Research Data, Nov 2017 Sub (2000–2015) < Katrina/Rita Population Adjustment>—Linked to County attributes—total U.S., 1969–2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 submission.
Dignam JJ, Zhang Q (2012) The use and interpretation of competing risks regression models. Clin Cancer Res 18:2301–2308. https://doi.org/10.1158/1078-0432.CCR-11-2097 CrossRefPubMedPubMedCentral
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509 CrossRef
Moss JL, Liu B, Feuer EJ (2017) Urban/rural differences in breast and cervical cancer incidence: the mediating roles of socioeconomic status and provider density. Women’s Heal Issues 27:683–691. https://doi.org/10.1016/j.whi.2017.09.008 CrossRef
Pan H, Walker G, Grant S et al (2017) Insurance status and racial disparities in cancer-specific mortality in the United States: a population-based analysis. Cancer Epidemiol Biomark Prev 26:869–875. https://doi.org/10.1158/1055-9965.EPI-16-0976 CrossRef
Sposto R, Keegan TH, Vigen C et al (2016) The effect of patient and contextual characteristics on racial/ethnic disparity in breast cancer mortality. Cancer Epidemiol Biomark Prev 25:1064–1072. https://doi.org/10.1158/1055-9965.EPI-15-1326 CrossRef
Tao L, Gomez SL, Keegan TH et al (2015) Breast cancer mortality in african-american and non-hispanic white women by molecular subtype and stage at diagnosis: a population-based study. Cancer Epidemiol Biomark Prev 24:1039–1045. https://doi.org/10.1158/1055-9965.EPI-15-0243 CrossRef
Davis MB, Newman LA (2018) Breast cancer disparities how can we leverage genomics to improve outcomes? Surg Oncol Clin N Am 27:217–234. https://doi.org/10.1016/j.soc.2017.07.009 CrossRefPubMed
Martin AM, Cagney DN, Catalano PJ et al (2017) Brain metastases in newly diagnosed breast cancer: a population-based study. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2017.0001 CrossRefPubMedPubMedCentral
Gomez SL, Glaser SL, Horn-Ross PL et al (2014) Cancer research in Asian American, native Hawaiian, and Pacific Islander populations: accelerating cancer knowledge by acknowledging and leveraging heterogeneity. Cancer Epidemiol Biomark Prev 23:2202–2205. https://doi.org/10.1158/1055-9965.EPI-14-0624 CrossRef
- Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
- Springer US
Breast Cancer Research and Treatment
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
Neu im Fachgebiet Onkologie
Mail Icon II